BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alderson MR, Sethna V, Newhouse LC, Lamola S, Dhere R. Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®). Hum Vaccin Immunother 2021;17:2670-7. [PMID: 33625961 DOI: 10.1080/21645515.2021.1874219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghia CJ, Horn EK, Rambhad G, Perdrizet J, Chitale R, Wasserman MD. Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India. Infect Dis Ther 2021. [PMID: 34313958 DOI: 10.1007/s40121-021-00498-4] [Reference Citation Analysis]
2 Zintgraff J, Gagetti P, Napoli D, Sanchez Eluchans N, Irazu L, Moscoloni M, Regueira M, Lara CS, Corso A; Argentina Spn Working Group. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine 2021:S0264-410X(21)01616-9. [PMID: 34920903 DOI: 10.1016/j.vaccine.2021.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tyrrell G, Lee C, Eurich D. Is there a need for pneumococcal vaccination programs for the homeless to prevent invasive pneumococcal disease? Expert Rev Vaccines 2021;:1-9. [PMID: 34365882 DOI: 10.1080/14760584.2021.1966301] [Reference Citation Analysis]
4 Perdrizet J, Farkouh RA, Horn EK, Hayford K, Sings HL, Wasserman MD. The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert Rev Vaccines 2022;:1-13. [PMID: 35191368 DOI: 10.1080/14760584.2022.2040989] [Reference Citation Analysis]